FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
WEDNESDAY, Aug. 8, 2018 -- Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.
The drug was approved to treat relapsed or refractory mycosis...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news